The Effect of Timing of Transcranial Direct Current Stimulation (tDCS) for Enhancing Learning During Cognitive Training

Effects on Learning Clinical Trial

Official title:

The Effect of Timing of Transcranial Direct Current Stimulation (tDCS) for Enhancing Learning During Cognitive Training

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01339585
• Other study ID #: HREC 11064
• Status: Completed
• Phase: N/A
• First received: April 1, 2011
• Last updated: August 11, 2014
• Start date: May 2011

Study information

• Verified date: August 2014
• Source: The University of New South Wales
• Contact: n/a
• Is FDA regulated: No
• Health authority: Australia: Therapeutic Goods Administration
• Study type: Interventional

Clinical Trial Summary

This project will investigate a novel strategy for enhancing cognitive training (CT). Specifically, the investigators aim to combine a non-invasive form of brain stimulation (tDCS) with CT. This study will examine the optimal time interval - whether tDCS should be administered either before or during CT.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 20
• Est. primary completion date: May 2014
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Both
• Age group: 18 Years to 40 Years

Eligibility

Inclusion Criteria:

• Participants will be healthy right-handed subjects aged 18 to 40 years.

Exclusion Criteria:

• Concurrent medication likely to affect mental performance,

• Current history of drug or alcohol abuse or dependence,

• Any psychiatric or neurological disorder,

• Recent head injury, or history of seizure or stroke.

Study Design

Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Single Blind (Subject), Primary Purpose: Basic Science

Related Conditions & MeSH terms

• Effects on Learning

Intervention

Device:
• Transcranial direct current stimulation (tDCS)
Eldith Direct Current Stimulator (NeuroConn GmbH, Germany)

Locations

Country	Name	City	State
Australia	School of Psychiatry	Sydney	New South Wales

Sponsors (1)

Lead Sponsor	Collaborator
The University of New South Wales

Country where clinical trial is conducted

Australia, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Change in performance across each condition.	D prime, number of correct responses, and number of errors.	Over 2 days, with each condition conducted 1 month apart.	No